The National Institutes of Health (NIH) National Cancer Institute has granted $124,000 to Aastrom Biosciences, Inc. to develop an immunotherapeutic treatment of malignant melanoma using AastromReplicell System cell production technology.
Metal Implants Can Lead to Allergic Contact Dermatitis
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Mediterranean Diet May Improve Responses to Immune Checkpoint Blockade for Advanced Melanoma
The Cutaneous Connection: JAK Inhibitor Safety for Treating AD
Air Pollution from Wildfire Smoke Can Exacerbate Skin Conditions
Highlights from AAD 2023
2 Clarke Drive Cranbury, NJ 08512